Literature DB >> 23514289

Norovirus and medically attended gastroenteritis in U.S. children.

Daniel C Payne1, Jan Vinjé, Peter G Szilagyi, Kathryn M Edwards, Mary Allen Staat, Geoffrey A Weinberg, Caroline B Hall, James Chappell, David I Bernstein, Aaron T Curns, Mary Wikswo, S Hannah Shirley, Aron J Hall, Benjamin Lopman, Umesh D Parashar.   

Abstract

BACKGROUND: Cases of rotavirus-associated acute gastroenteritis have declined since the introduction of rotavirus vaccines, but the burden of norovirus-associated acute gastroenteritis in children remains to be assessed.
METHODS: We conducted active surveillance for laboratory-confirmed cases of norovirus among children younger than 5 years of age with acute gastroenteritis in hospitals, emergency departments, and outpatient clinical settings. The children resided in one of three U.S. counties during the years 2009 and 2010. Fecal specimens were tested for norovirus and rotavirus. We calculated population-based rates of norovirus-associated acute gastroenteritis and reviewed billing records to determine medical costs; these data were extrapolated to the U.S. population of children younger than 5 years of age.
RESULTS: Norovirus was detected in 21% of young children (278 of 1295) seeking medical attention for acute gastroenteritis in 2009 and 2010, with norovirus detected in 22% (165 of 742) in 2009 and 20% (113 of 553) in 2010 (P=0.43). The virus was also detected in 4% of healthy controls (19 of 493) in 2009. Rotavirus was identified in 12% of children with acute gastroenteritis (152 of 1295) in 2009 and 2010. The respective rates of hospitalization, emergency department visits, and outpatient visits for the norovirus were 8.6, 146.7, and 367.7 per 10,000 children younger than 5 years of age in 2009 and 5.8, 134.3, and 260.1 per 10,000 in 2010, with an estimated cost per episode of $3,918, $435, and $151, respectively, in 2009. Nationally, we estimate that the average numbers of annual hospitalizations, emergency department visits, and outpatient visits due to norovirus infection in 2009 and 2010 among U.S. children in this age group exceeded 14,000, 281,000, and 627,000, respectively, with more than $273 million in treatment costs each year.
CONCLUSIONS: Since the introduction of rotavirus vaccines, norovirus has become the leading cause of medically attended acute gastroenteritis in U.S. children and is associated with nearly 1 million health care visits annually. (Funded by the Centers for Disease Control and Prevention.).

Entities:  

Mesh:

Year:  2013        PMID: 23514289      PMCID: PMC4618551          DOI: 10.1056/NEJMsa1206589

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

Review 1.  Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review.

Authors:  Rishi Desai; Christal D Hembree; Andreas Handel; Jonathan E Matthews; Benjamin W Dickey; Sharla McDonald; Aron J Hall; Umesh D Parashar; Juan S Leon; Benjamin Lopman
Journal:  Clin Infect Dis       Date:  2012-04-04       Impact factor: 9.079

2.  Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006.

Authors:  Jacqueline E Tate; Jeffry D Mutuc; Catherine A Panozzo; Daniel C Payne; Margaret M Cortese; Jennifer E Cortes; Catherine Yen; Douglas H Esposito; Benjamin A Lopman; Manish M Patel; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

Review 3.  Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.

Authors:  Jacqueline E Tate; Margaret M Cortese; Daniel C Payne; Aaron T Curns; Catherine Yen; Douglas H Esposito; Jennifer E Cortes; Benjamin A Lopman; Manish M Patel; Jon R Gentsch; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

4.  Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.

Authors:  Samer S El-Kamary; Marcela F Pasetti; Paul M Mendelman; Sharon E Frey; David I Bernstein; John J Treanor; Jennifer Ferreira; Wilbur H Chen; Richard Sublett; Charles Richardson; Robert F Bargatze; Marcelo B Sztein; Carol O Tacket
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

5.  Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases.

Authors:  Margaret M Cortese; Jacqueline E Tate; Lone Simonsen; Laurel Edelman; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

6.  Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.

Authors:  Christina Atchison; Ben Lopman; William John Edmunds
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

7.  Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States.

Authors:  Catherine Yen; Mary E Wikswo; Ben A Lopman; Jan Vinje; Umesh D Parashar; Aron J Hall
Journal:  Clin Infect Dis       Date:  2011-08-10       Impact factor: 9.079

8.  Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

Authors:  Daniel C Payne; Mary Allen Staat; Kathryn M Edwards; Peter G Szilagyi; Geoffrey A Weinberg; Caroline B Hall; James Chappell; Aaron T Curns; Mary Wikswo; Jacqueline E Tate; Benjamin A Lopman; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2011-06-23       Impact factor: 9.079

9.  Burden of childhood rotavirus disease on health systems in the United States.

Authors:  T Christopher Mast; Emmanuel B Walter; Monique Bulotsky; Shazia S Khawaja; Daniel J DiStefano; Mary K Sandquist; Walter L Straus; Mary Allen Staat
Journal:  Pediatr Infect Dis J       Date:  2010-02       Impact factor: 2.129

Review 10.  Norovirus gastroenteritis.

Authors:  Roger I Glass; Umesh D Parashar; Mary K Estes
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

View more
  237 in total

1.  Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens.

Authors:  Gillian A M Tarr; Linda Chui; Bonita E Lee; Xiao-Li Pang; Samina Ali; Alberto Nettel-Aguirre; Otto G Vanderkooi; Byron M Berenger; James Dickinson; Phillip I Tarr; Steven Drews; Judy MacDonald; Kelly Kim; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

Review 2.  Chloride channel-targeted therapy for secretory diarrheas.

Authors:  Jay R Thiagarajah; A S Verkman
Journal:  Curr Opin Pharmacol       Date:  2013-08-27       Impact factor: 5.547

3.  First vaccines targeting 'cruise ship virus' sail into clinical trials.

Authors:  Cassandra Willyard
Journal:  Nat Med       Date:  2013-09       Impact factor: 53.440

Review 4.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

5.  Genotypic and epidemiologic trends of norovirus outbreaks in the United States, 2009 to 2013.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; S Hannah Shirley; David Lee; Jan Vinjé
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

6.  Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics.

Authors:  Andrej Steyer; Monika Jevšnik; Miroslav Petrovec; Marko Pokorn; Štefan Grosek; Adela Fratnik Steyer; Barbara Šoba; Tina Uršič; Tjaša Cerar Kišek; Marko Kolenc; Marija Trkov; Petra Šparl; Raja Duraisamy; W Ian Lipkin; Sara Terzić; Mojca Kolnik; Tatjana Mrvič; Amit Kapoor; Franc Strle
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

7.  Assessment of gastroenteric viruses from wastewater directly discharged into Uruguay River, Uruguay.

Authors:  M Victoria; L F L Tort; M García; A Lizasoain; L Maya; J P G Leite; M P Miagostovich; J Cristina; R Colina
Journal:  Food Environ Virol       Date:  2014-04-29       Impact factor: 2.778

Review 8.  Developments in understanding acquired immunity and innate susceptibility to norovirus and rotavirus gastroenteritis in children.

Authors:  Daniel C Payne; Umesh D Parashar; Benjamin A Lopman
Journal:  Curr Opin Pediatr       Date:  2015-02       Impact factor: 2.856

9.  Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.

Authors:  Yee Ching Ng; Ye Won Kim; Jeong-Su Lee; Sung Joon Lee; Moon Jung Song
Journal:  J Microbiol       Date:  2018-08-23       Impact factor: 3.422

10.  Replication of human noroviruses in stem cell-derived human enteroids.

Authors:  Khalil Ettayebi; Sue E Crawford; Kosuke Murakami; James R Broughman; Umesh Karandikar; Victoria R Tenge; Frederick H Neill; Sarah E Blutt; Xi-Lei Zeng; Lin Qu; Baijun Kou; Antone R Opekun; Douglas Burrin; David Y Graham; Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Science       Date:  2016-08-25       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.